ArticlePharmaceuticals (Basel, Switzerland)2022

Dehydrocrenatidine Induces Liver Cancer Cell Apoptosis by Suppressing JNK-Mediated Signaling.

Bharath Kumar Velmurugan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.